Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

Jacques Tebib; Xavier Mariette; Pierre Bourgeois; René-Marc Flipo; Philippe Gaudin; Xavier Le Loët; Paul Gineste; Laurent Guy; Colin D Mansfield; Alain Moussy; Patrice Dubreuil; Olivier Hermine; Jean Sibilia

doi:10.1186/ar2740

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

Arthritis Research & Therapy ◽

10.1186/ar2740 ◽

2009 ◽

Vol 11 (3) ◽

pp. R95 ◽

Cited By ~ 43

Author(s):

Jacques Tebib ◽

Xavier Mariette ◽

Pierre Bourgeois ◽

René-Marc Flipo ◽

Philippe Gaudin ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Open Label ◽

Label Dose ◽

Dose Ranging

Download Full-text

Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study

Clinical Rheumatology ◽

10.1007/s10067-015-2988-9 ◽

2015 ◽

Vol 35 (4) ◽

pp. 1059-1064 ◽

Cited By ~ 9

Author(s):

Arvind Chopra ◽

S. Chandrashekara ◽

Rajgopalan Iyer ◽

Liza Rajasekhar ◽

Naresh Shetty ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Phase 2 ◽

Open Label ◽

Safety And Efficacy ◽

Parallel Group ◽

Dose Ranging

Download Full-text

Faculty Opinions recommendation of An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1070806.523739 ◽

2007 ◽

Author(s):

Robert Sidbury

Keyword(s):

Atopic Eczema ◽

Open Label ◽

Label Dose ◽

Dose Ranging

Download Full-text

Tocilizumab Improves Arterial Stiffness As Well As Other Biologics with Methotrexate-Resistant Active Rheumatoid Arthritis-An Open Label, Randomized Cohort Multi Center Study

OMICS Journal of Radiology ◽

10.4172/2167-7964.1000186 ◽

2015 ◽

Vol 04 (03) ◽

Author(s):

Kensuke Kume

Keyword(s):

Rheumatoid Arthritis ◽

Arterial Stiffness ◽

Active Rheumatoid Arthritis ◽

Open Label ◽

Multi Center Study ◽

Center Study

Download Full-text

Faculty Opinions recommendation of Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726215276.793560307 ◽

2019 ◽

Author(s):

Olivier Lortholary

Keyword(s):

Cryptococcal Meningitis ◽

Open Label ◽

Label Dose ◽

Dose Ranging

Download Full-text

THU0173 Filgotinib (GLPG0634), An Oral Jak1 Selective Inhibitor Is Effective as Monotherapy in Patients with Active Rheumatoid Arthritis: Results from A 24-Week Phase 2B Dose Ranging Study: Table 1.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.3862 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 247.1-247 ◽

Cited By ~ 7

Author(s):

A. Kavanaugh ◽

L. Ponce ◽

R. Cseuz ◽

O. Reshetko ◽

M. Stanislavchuk ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Selective Inhibitor ◽

Dose Ranging

Download Full-text

Abstract A221: Results of preclinical and clinical phase I/II open‐label dose‐ranging trial with HE3235, a synthetic adrenal hormone, in castrate‐resistant prostate cancer

10.1158/1535-7163.targ-09-a221 ◽

2009 ◽

Cited By ~ 2

Author(s):

Bruce Montgomery ◽

Michael Morris ◽

Charles Ryan ◽

Eva Corey ◽

Dwight Stickney ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Open Label ◽

Clinical Phase ◽

Adrenal Hormone ◽

Label Dose ◽

Castrate Resistant Prostate Cancer ◽

Dose Ranging ◽

Castrate Resistant

Download Full-text

Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(16)00074-8 ◽

2016 ◽

Vol 16 (7) ◽

pp. 809-818 ◽

Cited By ~ 102

Author(s):

Joshua Rhein ◽

Bozena M Morawski ◽

Kathy Huppler Hullsiek ◽

Henry W Nabeta ◽

Reuben Kiggundu ◽

...

Keyword(s):

Cryptococcal Meningitis ◽

Open Label ◽

Label Dose ◽

Dose Ranging

Download Full-text

Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs

Arthritis & Rheumatism ◽

10.1002/art.33383 ◽

2012 ◽

Vol 64 (3) ◽

pp. 617-629 ◽

Cited By ~ 260

Author(s):

Roy Fleischmann ◽

Maurizio Cutolo ◽

Mark C. Genovese ◽

Eun Bong Lee ◽

Keith S. Kanik ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Jak Inhibitor ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Dose Ranging ◽

Disease Modifying

Download Full-text

Erratum: Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

Arthritis & Rheumatism ◽

10.1002/art.30103 ◽

2010 ◽

Vol 62 (11) ◽

pp. 3518-3518 ◽

Cited By ~ 1

Author(s):

Jonathan Kay ◽

Eric L. Matteson ◽

Bhaskar Dasgupta ◽

Peter Nash ◽

Patrick Durez ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Ranging

Download Full-text

An open-label, dose-ranging study to assess the safety, efficacy, and pharmacokinetics of eltrombopag in treating thrombocytopenia in patients with advanced sarcomas receiving doxorubicin and ifosfamide.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps334 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS334-TPS334

Author(s):

S. P. Chawla ◽

A. P. Staddon ◽

C. Messam ◽

A. M. Graham ◽

Y. M. Mostafa Kamel

Keyword(s):

Open Label ◽

Label Dose ◽

Dose Ranging

Download Full-text